Participation in upcoming investor conferences

Summary by AI BETAClose X

Oxford Nanopore Technologies plc announced its participation in two upcoming investor conferences in September. The company's Chief Executive Officer and Chief Financial Officer will attend the Morgan Stanley Global Healthcare Conference on September 15th, followed by the RBC Capital Markets Pharma Services & Life Science Tools Virtual Conference on September 22nd, where the Chief Financial Officer will present. Webcasts of both fireside chats will be available on the company's Investor Relations website for at least 30 days post-event.

Disclaimer*

Oxford Nanopore Technologies plc
09 September 2026
 

9 September 2026

Oxford Nanopore Technologies plc

("Oxford Nanopore" or the "Company")

Oxford Nanopore to participate in upcoming investor conferences

Oxford Nanopore Technologies plc (LSE: ONT), the company delivering a new generation of molecular sensing technology based on nanopores, will be participating in the following investor conferences in September.

·      Morgan Stanley Global Healthcare Conference, New York

Format: Fireside chat and investor meetings

Date: Tuesday, 15 September

Francis Van Parys, Chief Executive Officer, and Nick Keher, Chief Financial Officer, will participate in an analyst led fireside chat at 10:45am EDT (3:45pm BST).

 

·      RBC Capital Markets Pharma Services & Life Science Tools Virtual Conference

Format: Fireside chat and investor meetings

Date: Tuesday, 22 September

Nick Keher, Chief Financial Officer, will participate in an analyst led fireside chat at 3:15pm BST (10:15am EDT).

A webcast of both fireside chats will be accessible through Oxford Nanopore's Investor Relations website. The webcasts will be available for replay for at least 30 days after the event.

-ENDS-

For further information, please contact:

Oxford Nanopore Technologies plc

Investors:        ir@nanoporetech.com

Media:             media@nanoporetech.com

 

Teneo (communications adviser to the Company)

Tom Murray, Lisa Jarrett-Kerr

+44 (0) 20 7353 4200

OxfordNanoporeTechnologies@teneo.com

 

About Oxford Nanopore Technologies plc:

Oxford Nanopore Technologies has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.  Oxford Nanopore's technology also has the potential to provide broad, high impact, rapid insights in a number of areas including healthcare, food and agriculture.

For more information please visit: www.nanoporetech.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100